Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$3.72 - $5.4 $58,712 - $85,228
-15,783 Reduced 50.37%
15,554 $63,000
Q4 2022

Feb 13, 2023

BUY
$3.41 - $12.93 $32,306 - $122,498
9,474 Added 43.33%
31,337 $157,000
Q3 2022

Nov 14, 2022

BUY
$12.59 - $17.67 $11,708 - $16,433
930 Added 4.44%
21,863 $286,000
Q2 2022

Aug 12, 2022

BUY
$10.58 - $17.5 $221,471 - $366,327
20,933 New
20,933 $268,000

Others Institutions Holding NGM

About NGM BIOPHARMACEUTICALS INC


  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.